Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yacine Wissam"'
Autor:
Yacine Wissam, Laila Belcaid, Ruth Wittoek, Vanessa Smith, Amber Vanhaecke, Sofie De Schepper, Lennart Jans, Daphné t’Kint de Roodenbeke, Andrea Gombos, Sandrine Aspeslagh
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 101-105 (2019)
Immune checkpoint inhibition has revolutionized the treatment for numerous cancer patients; however, the spectrum of immune-related adverse events (irAEs) remains to be fully uncovered. We report a 48-year-old woman who was treated in the Phase III I
Externí odkaz:
https://doaj.org/article/3c963379cc8f4b81aa4a3aafcf0b962f
Autor:
Silvia Camera, Tugba Akin Telli, Erwin Woff, Caroline Vandeputte, Pashalina Kehagias, Thomas Guiot, Gabriela Critchi, Yacine Wissam, Giacomo Bregni, Elena Trevisi, Andrea Pretta, Chiara Senti, Sophia Leduc, Paraskevas Gkolfakis, Frédéric Hoerner, Françoise Rothé, Francesco Sclafani, Patrick Flamen, Amelie Deleporte, Alain Hendlisz
Publikováno v:
Cancers, Vol 12, Iss 10, p 2752 (2020)
Introduction: Decision making in refractory colorectal cancer (rCRC) is challenging, with limited data available to predict patient outcome. We conducted a study to assess the pace of cancer progression as a potential prognostic and decision tool. Me
Externí odkaz:
https://doaj.org/article/367d5eb536e04e769935931bc25b600d
Autor:
Vanessa Smith, Andrea Gombos, Amber Vanhaecke, Ruth Wittoek, Yacine Wissam, Daphné t'Kint de Roodenbeke, Laila Belcaid, Lennart Jans, Sandrine Aspeslagh, Sofie De Schepper
Publikováno v:
Journal of Immunotherapy and Precision Oncology. 2:101-105
Immune checkpoint inhibition has revolutionized the treatment for numerous cancer patients; however, the spectrum of immune-related adverse events (irAEs) remains to be fully uncovered. We report a 48-year-old woman who was treated in the Phase III I
Autor:
Tugba Akin Telli, Françoise Rothé, Francesco Sclafani, Caroline Vandeputte, Gabriela Critchi, Silvia Camera, Giacomo Bregni, Chiara Senti, Elena Trevisi, Yacine Wissam, Frédéric Hoerner, Amélie Deleporte, Paraskevas Gkolfakis, Andrea Pretta, Pashalina Kehagias, Patrick Flamen, Alain Hendlisz, Erwin Woff, Thomas Guiot, Sophia Leduc
Publikováno v:
Cancers
Volume 12
Issue 10
Cancers, 12 (10
Cancers, Vol 12, Iss 2752, p 2752 (2020)
Cancers (Basel), 12 (10
Volume 12
Issue 10
Cancers, 12 (10
Cancers, Vol 12, Iss 2752, p 2752 (2020)
Cancers (Basel), 12 (10
Introduction: Decision making in refractory colorectal cancer (rCRC) is challenging, with limited data available to predict patient outcome. We conducted a study to assess the pace of cancer progression as a potential prognostic and decision tool. Me